Long-term Growth Hormone Therapy in an Adolescent Boy with 45,X/46,XidicY(p11) - 07/08/11
Doi : 10.1016/j.jpeds.2009.03.018
Frances M. Guevarra, MD, Saroj Nimkarn, MD, Maria I. New, MD ⁎ 
, Karen Lin-Su, MD
, Karen Lin-Su, MD Pediatric Endocrinology, Adrenal Steroid Disorders Program, Department of Pediatrics, The Mount Sinai School of Medicine, New York, NY
Reprint requests: Maria I. New, MD, Mount Sinai School of Medicine, Department of Pediatrics, 1 Gustave L. Levy Pl, Box 1198, New York, NY 10029.Abstract |
A 17-year-old boy with chromosomal mosaicism resulting in a 45,X/46,X,idic(Y)(p11) karyotype came to medical attention at the age of 10 years because of short stature. He was treated with recombinant growth hormone for 6.6 years and has achieved a near final adult height of 172.5 cm. His clinical features included second-degree hypospadias, some stigmata of Turner syndrome, and spontaneous progression through puberty. We report long-term use of growth hormone in a male adolescent with isodicentric Yq.
Le texte complet de cet article est disponible en PDF.Mots-clés : MGD, TS
Plan
| The authors declare no conflicts of interest. |
© 2009
Mosby, Inc. Tous droits réservés.
Vol 155 - N° 5
P. 752 - novembre 2009 Retour au numéro
Article précédent
- Retrospective Diagnosis of Congenital Cytomegalovirus Infection at a School for the Deaf by Using Preserved Dried Umbilical Cord
- Masato Tagawa, Hideo Tanaka, Masako Moriuchi, Hiroyuki Moriuchi
- CHAOS in the Delivery Room: A Dire Emergency
- Sanjay Chawla, Girija Natarajan, Nitin Chouthai, Deepak Kamat
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?